Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spectrila vs Asparaginase Medac in Children with ALL
NCT00784017Phase 3Completed
- Sponsor
- medac GmbH
- Start
- Oct 2008
- Primary completion
- Oct 2012
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Asparaginase in acute lymphoblastic leukemia (ALL), sponsored by medac GmbH. Started Oct 2008; status: completed.
02
Drugs
Asparaginase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00784017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784017.